These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 12801798)

  • 21. The use of genomics in microbial vaccine development.
    Bambini S; Rappuoli R
    Drug Discov Today; 2009 Mar; 14(5-6):252-60. PubMed ID: 19150507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome- and proteome-wide screening strategies for antigen discovery and immunogen design.
    Schussek S; Trieu A; Doolan DL
    Biotechnol Adv; 2014; 32(2):403-14. PubMed ID: 24389084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Update on "Reverse Vaccinology": The Pathway from Genomes and Epitope Predictions to Tailored, Recombinant Vaccines.
    Michalik M; Djahanschiri B; Leo JC; Linke D
    Methods Mol Biol; 2022; 2412():45-71. PubMed ID: 34918241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design.
    Rappuoli R; Bottomley MJ; D'Oro U; Finco O; De Gregorio E
    J Exp Med; 2016 Apr; 213(4):469-81. PubMed ID: 27022144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reverse vaccinology approach for the identifications of potential vaccine candidates against Salmonella.
    Li J; Qiu J; Huang Z; Liu T; Pan J; Zhang Q; Liu Q
    Int J Med Microbiol; 2021 Jul; 311(5):151508. PubMed ID: 34182206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PanRV: Pangenome-reverse vaccinology approach for identifications of potential vaccine candidates in microbial pangenome.
    Naz K; Naz A; Ashraf ST; Rizwan M; Ahmad J; Baumbach J; Ali A
    BMC Bioinformatics; 2019 Mar; 20(1):123. PubMed ID: 30871454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural vaccinology starts to deliver.
    Dormitzer PR; Grandi G; Rappuoli R
    Nat Rev Microbiol; 2012 Dec; 10(12):807-13. PubMed ID: 23154260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The bacterial pan-genome and reverse vaccinology.
    Tettelin H
    Genome Dyn; 2009; 6():35-47. PubMed ID: 19696492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of reverse vaccinology in Schistosoma vaccine development: advances and prospects].
    Feng XG; Sui CY; Yuan CX; Shao DH; Chen JX; Lin JJ
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):237-47. PubMed ID: 18038788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccines based on structure-based design provide protection against infectious diseases.
    Thomas S; Luxon BA
    Expert Rev Vaccines; 2013 Nov; 12(11):1301-11. PubMed ID: 24090172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 vaccine design using reverse and structural vaccinology, ontology-based literature mining and machine learning.
    Huffman A; Ong E; Hur J; D'Mello A; Tettelin H; He Y
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35649389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computer Aided Reverse Vaccinology: A Game-changer Approach for Vaccine Development.
    Srivastava P; Jain CK
    Comb Chem High Throughput Screen; 2023; 26(10):1813-1821. PubMed ID: 36200250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integration of Novel Materials and Advanced Genomic Technologies into New Vaccine Design.
    Liao W; Zhang TT; Gao L; Lee SS; Xu J; Zhang H; Yang Z; Liu Z; Li W
    Curr Top Med Chem; 2017; 17(20):2286-2301. PubMed ID: 28240182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The genome revolution in vaccine research.
    Capecchi B; Serruto D; Adu-Bobie J; Rappuoli R; Pizza M
    Curr Issues Mol Biol; 2004 Jan; 6(1):17-27. PubMed ID: 14632256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reverse vaccinology.
    Rappuoli R
    Curr Opin Microbiol; 2000 Oct; 3(5):445-50. PubMed ID: 11050440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A reverse vaccinology approach for the identification of potential vaccine candidates from Leishmania spp.
    John L; John GJ; Kholia T
    Appl Biochem Biotechnol; 2012 Jul; 167(5):1340-50. PubMed ID: 22434357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genes to genetic immunization: identification of bacterial vaccine candidates.
    Allan E; Wren BW
    Methods; 2003 Nov; 31(3):193-8. PubMed ID: 14511951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach.
    Mora M; Donati C; Medini D; Covacci A; Rappuoli R
    Curr Opin Microbiol; 2006 Oct; 9(5):532-6. PubMed ID: 16890009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology.
    Ni Z; Chen Y; Ong E; He Y
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antigen identification starting from the genome: a "Reverse Vaccinology" approach applied to MenB.
    Palumbo E; Fiaschi L; Brunelli B; Marchi S; Savino S; Pizza M
    Methods Mol Biol; 2012; 799():361-403. PubMed ID: 21993656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.